Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan.
Md Razeen Ashraf HussainLindsey HiebertAya SugiyamaSerge OuobaE BunthenKo KoTomoyuki AkitaShuichi KanekoTatsuya KantoJohn W WardJunko TanakaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Although in Japan all-inclusive decline in HBV- and HCV-related services were lower than in other countries, a greater decline was observed in HBV and HCV screening and diagnosis than in treatment initiation. Prolonged anxiety/fear among patients, and loss of staff and facilities from the COVID-19 response activities must be addressed to achieve elimination of hepatitis by 2030.